US Equities Analysis

DHR — Danaher Corporation

DHR DHR Price Chart

Danaher Corporation (DHR) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Danaher Corporation is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $183.63.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$183.63
Latest Date2026-06-10
Expected Return (Annualized)0.85%
Risk / Std Dev (Annualized)28.05%
Sharpe Ratio (rf=4.5%)-0.13

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 0.85% with an annualized volatility of 28.05%. The Sharpe ratio of -0.13 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap129.97B
Enterprise Value143.96B
Trailing P/E36.51
Forward P/E20.18
Price to Book2.45
Price to Sales5.25
EV/Revenue5.81
EV/EBITDA18.14

| Profitability | | | Profit Margin | 14.89% | | Operating Margin | 22.94% | | ROE | 7.08% | | ROA | 4.19% |

| Growth | | | Revenue Growth | 3.7% | | Earnings Growth | 9.8% |

| Dividend | | | Dividend Yield | 87.0% | | Payout Ratio | 26.36% | | 5Y Avg Yield | 44.0% |

| Financial Health | | | Total Revenue | 24.78B | | Total Debt | 19.68B | | Total Cash | 5.7B | | Free Cash Flow | 4.57B | | Operating Cash Flow | 6.44B |

| Price & Technical | | | 52W High | $242.8$ | | 52W Low | $160.93$ | | 50-Day Avg | $181.0$ | | 200-Day Avg | $205.14$ | | Beta | 0.83 | | Shares Outstanding | 0.71B | | Float Shares | 0.63B | | Insider Holdings | 10.74% | | Institutional Holdings | 84.76% | | Short Ratio | 1.89 | | Short % of Float | 1.47% |

| Analyst Targets | | | Target High | $310.0$ | | Target Low | $200.0$ | | Target Mean | $244.27$ | | Target Median | $245.0$ | | # of Analysts | 22 | | Recommendation | strong_buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity dhr health-care life-sciences-tools--services nasdaq